| Abstrakt: |
The article discusses a clinical trial, NCT06672497, focusing on breast cancer and gynecological cancer patients participating in an exercise study to assess the effects of chemotherapy on muscle mitochondrial oxidative capacity. Participants will ride a stationary bicycle, and their quadriceps muscle will be evaluated non-invasively. The study aims to measure O2Hb, HHb, and TSI using the NIRS PortaMon device during an on-off kinetics protocol to understand the impact of chemotherapy on skeletal muscle health. The trial is observational, with a prospective cohort design, and is currently recruiting female participants aged 20 and above in the United States. [Extracted from the article] |
